Tuberculosis preventive treatment in children and adolescents: an observational study of secondary data
- PMID: 36868266
- PMCID: PMC10373147
- DOI: 10.1016/j.jped.2023.02.002
Tuberculosis preventive treatment in children and adolescents: an observational study of secondary data
Abstract
Objective: To analyze the effectiveness, safety, outcomes, and associated factors of tuberculosis preventive treatment (TPT) in children and adolescents in Paraná, southern Brazil.
Method: This was an observational cohort study with a retrospective collection of secondary data from the TPT information systems of the state of Paraná from 2009 to 2016, and tuberculosis in Brazil from 2009 to 2018.
Results: In total, 1,397 people were included. In 95.4% of the individuals, the indication for TPT was a history of patient-index contact with pulmonary tuberculosis. Isoniazid was used in 99.9% of the cases with TPT, and 87.7% completed the treatment. The TPT protection was 98.7%. Among the 18 people who had TB, 14 (77.8%) became ill after the second year of treatment, and four (22.2%) in the first two years (p < 0.001). Adverse events were reported in 3.3% of cases, most of them were gastrointestinal and medication was discontinued in only 2 (0.1%) patients. No risk factors associated with the illness were observed.
Conclusions: The authors observed a low rate of illness in pragmatics routine conditions in TPT for children and adolescents, especially within the first two years after the end of treatment, with good tolerability and a good percentage of adherence to the treatment. TPT should be encouraged to achieve the goals of the End TB Strategy of the World Health Organization as an essential strategy to reduce the incidence rate of the disease, but studies with new schemes must continue to be carried out in real-life scenarios.
Keywords: Household contacts; Latent infection; Latent tuberculosis; Pediatrics; Prevention.
Copyright © 2023. Published by Elsevier Editora Ltda.
Conflict of interest statement
Conflicts of interest The authors declare no conflicts of interest.
References
-
- World Health Organization (WHO). The end TB strategy Geneva: WHO; 2015 [cited 2017 Nov 8]. 20 p. Available from: http://www.who.int/tb/End_TB_brochure.pdf?ua=1.
-
- World Health Organization (WHO) WHO; Geneva: 2022. Global tuberculosis report 2022.
-
- Brasil. Ministério da Saúde . Estratégias para 2021-2025. Ministério da Saúde; Brasília: 2021. Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis. Brasil Livre da Tuberculose. Plano Nacional pelo Fim da Tuberculose como Problema de Saúde Pública; p. 52. 2021-2025Ministério da Saúdep.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
